Celiac Disease Diagnosis: Simple Rules Are Better Than Complicated Algorithms

Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of medicine Vol. 123; no. 8; pp. 691 - 693
Main Authors Catassi, Carlo, Fasano, Alessio
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.2010
Elsevier
Elsevier Sequoia S.A
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal biopsy showing the autoimmune insult typical of celiac disease. The biopsy, considered the diagnostic gold standard, has been recently questioned as a reliable and conclusive test for every case. Indeed, the wide variability of celiac disease-related findings suggests that it is difficult to conceptualize the diagnostic process into rigid algorithms that do not always cover the clinical complexity of this disease. Instead we find clinically useful the shifting to a quantitative approach that can be defined as the “4 out of 5” rule: the diagnosis of celiac disease is confirmed if at least 4 of the following 5 criteria are satisfied: typical symptoms of celiac disease; positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer; human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes; celiac enteropathy at the small bowel biopsy; and response to the gluten-free diet.
AbstractList Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal biopsy showing the autoimmune insult typical of celiac disease. The biopsy, considered the diagnostic gold standard, has been recently questioned as a reliable and conclusive test for every case. Indeed, the wide variability of celiac disease-related findings suggests that it is difficult to conceptualize the diagnostic process into rigid algorithms that do not always cover the clinical complexity of this disease. Instead we find clinically useful the shifting to a quantitative approach that can be defined as the "4 out of 5" rule: the diagnosis of celiac disease is confirmed if at least 4 of the following 5 criteria are satisfied: typical symptoms of celiac disease; positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer; human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes; celiac enteropathy at the small bowel biopsy; and response to the gluten-free diet. [PUBLICATION ABSTRACT]
Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal biopsy showing the autoimmune insult typical of celiac disease. The biopsy, considered the diagnostic gold standard, has been recently questioned as a reliable and conclusive test for every case. Indeed, the wide variability of celiac disease-related findings suggests that it is difficult to conceptualize the diagnostic process into rigid algorithms that do not always cover the clinical complexity of this disease. Instead we find clinically useful the shifting to a quantitative approach that can be defined as the "4 out of 5" rule: the diagnosis of celiac disease is confirmed if at least 4 of the following 5 criteria are satisfied: typical symptoms of celiac disease; positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer; human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes; celiac enteropathy at the small bowel biopsy; and response to the gluten-free diet.Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal biopsy showing the autoimmune insult typical of celiac disease. The biopsy, considered the diagnostic gold standard, has been recently questioned as a reliable and conclusive test for every case. Indeed, the wide variability of celiac disease-related findings suggests that it is difficult to conceptualize the diagnostic process into rigid algorithms that do not always cover the clinical complexity of this disease. Instead we find clinically useful the shifting to a quantitative approach that can be defined as the "4 out of 5" rule: the diagnosis of celiac disease is confirmed if at least 4 of the following 5 criteria are satisfied: typical symptoms of celiac disease; positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer; human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes; celiac enteropathy at the small bowel biopsy; and response to the gluten-free diet.
Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal biopsy showing the autoimmune insult typical of celiac disease. The biopsy, considered the diagnostic gold standard, has been recently questioned as a reliable and conclusive test for every case. Indeed, the wide variability of celiac disease-related findings suggests that it is difficult to conceptualize the diagnostic process into rigid algorithms that do not always cover the clinical complexity of this disease. Instead we find clinically useful the shifting to a quantitative approach that can be defined as the “4 out of 5” rule: the diagnosis of celiac disease is confirmed if at least 4 of the following 5 criteria are satisfied: typical symptoms of celiac disease; positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer; human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes; celiac enteropathy at the small bowel biopsy; and response to the gluten-free diet.
Abstract Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented. The current diagnostic algorithm for celiac disease includes initial screening serological tests, followed by a confirmatory small intestinal biopsy showing the autoimmune insult typical of celiac disease. The biopsy, considered the diagnostic gold standard, has been recently questioned as a reliable and conclusive test for every case. Indeed, the wide variability of celiac disease-related findings suggests that it is difficult to conceptualize the diagnostic process into rigid algorithms that do not always cover the clinical complexity of this disease. Instead we find clinically useful the shifting to a quantitative approach that can be defined as the “4 out of 5” rule: the diagnosis of celiac disease is confirmed if at least 4 of the following 5 criteria are satisfied: typical symptoms of celiac disease; positivity of serum celiac disease immunoglobulin, A class autoantibodies at high titer; human leukocyte antigen (HLA)-DQ2 or DQ8 genotypes; celiac enteropathy at the small bowel biopsy; and response to the gluten-free diet.
Author Fasano, Alessio
Catassi, Carlo
Author_xml – sequence: 1
  givenname: Carlo
  surname: Catassi
  fullname: Catassi, Carlo
  organization: Mucosal Biology Research and Center for Celiac Research, University of Maryland, School of Medicine, Baltimore
– sequence: 2
  givenname: Alessio
  surname: Fasano
  fullname: Fasano, Alessio
  email: afasano@mbrc.umaryland.edu
  organization: Mucosal Biology Research and Center for Celiac Research, University of Maryland, School of Medicine, Baltimore
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23087559$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20670718$$D View this record in MEDLINE/PubMed
BookMark eNqVkl1rFDEUhoNU7Lb6D0QGQbyaNZlMMjNFhHX9hIpg63XIZE7arJlkTTKF_vtm2LVCQRav8vW8b5LznhN05LwDhJ4TvCSY8DebpRw3IwzLCuctXC0x6R6hBWGMlQ3h1RFaYIyrsqM1PUYnMW7yEneMP0HHFeYNbki7QN_WYI1UxQcTQUbIo7xyPpp4VlyYcWuh-DFZiMUqQPEeUoJQXF5LV6x9PjRKJhiKlb3ywaTrMT5Fj7W0EZ7tx1P089PHy_WX8vz756_r1XmpGGtT2deMEkl0RaTWPeWatYSwthkUbTWW1dD1vR56yVkHFLcdV5R3lDUNxv1Aa01P0eud7zb43xPEJEYTFVgrHfgpiobVbbZs-GGy7jCZL8_kywfkxk_B5W9kiNc0P2S2e7GHpj7XXmyDGWW4FX8KmoFXe0BGJa0O0ikT_3LZpWGsy1y941TwMQbQ9wjBYs5XbMQuXzHnK3Alcr5ZdvZApkySyXiXgjT2kPjdTgw5mhsDQURlwCkYTACVxODN_xooa1zuAvsLbiHe14uImAXiYu6_uf1InlDWkWzw9t8Gh--_A-Qz6MI
CODEN AJMEAZ
CitedBy_id crossref_primary_10_1002_acr_23200
crossref_primary_10_3390_nu13051684
crossref_primary_10_1519_SSC_0000000000000239
crossref_primary_10_1016_j_rgmx_2021_06_009
crossref_primary_10_3390_ijms23147719
crossref_primary_10_4103_jrms_JRMS_487_19
crossref_primary_10_1111_jhn_12032
crossref_primary_10_33549_physiolres_933876
crossref_primary_10_1016_j_med_2020_01_002
crossref_primary_10_1016_j_gastrohep_2013_12_006
crossref_primary_10_1080_1744666X_2021_1880320
crossref_primary_10_1016_j_mechatronics_2017_04_011
crossref_primary_10_1002_ajmg_a_35290
crossref_primary_10_1007_s00261_016_1034_y
crossref_primary_10_1080_15398285_2019_1711004
crossref_primary_10_1016_j_fmc_2017_09_005
crossref_primary_10_1016_j_anpedi_2010_09_025
crossref_primary_10_1016_j_taml_2024_100500
crossref_primary_10_1021_acs_jafc_0c01421
crossref_primary_10_1016_j_msard_2016_07_018
crossref_primary_10_1038_cmi_2010_68
crossref_primary_10_1016_j_dld_2012_03_006
crossref_primary_10_1007_s12098_017_2323_3
crossref_primary_10_36290_vnl_2019_006
crossref_primary_10_1586_17474124_2013_834125
crossref_primary_10_1080_17474124_2017_1274231
crossref_primary_10_1111_1747_0080_12270
crossref_primary_10_1111_apt_13155
crossref_primary_10_12998_wjcc_v3_i3_275
crossref_primary_10_3390_diseases3020086
crossref_primary_10_1177_0260106021990254
crossref_primary_10_1371_journal_pone_0157879
crossref_primary_10_1016_j_rgmxen_2022_03_008
crossref_primary_10_1186_s12876_020_01390_0
crossref_primary_10_3390_nu7115470
crossref_primary_10_3390_jpm12101582
crossref_primary_10_1016_j_cca_2012_05_015
crossref_primary_10_20964_2020_06_36
crossref_primary_10_1016_j_rgmx_2017_05_006
crossref_primary_10_3109_00365521_2011_589471
crossref_primary_10_1097_MPG_0b013e3182716861
crossref_primary_10_4292_wjgpt_v6_i4_207
crossref_primary_10_1016_j_ijmedinf_2011_08_001
crossref_primary_10_1016_j_rgmxen_2018_03_003
crossref_primary_10_1080_07853890_2017_1325968
crossref_primary_10_3390_nu15051089
crossref_primary_10_1177_23247096211053702
crossref_primary_10_1053_j_gastro_2014_04_027
crossref_primary_10_1016_j_cnd_2016_06_002
crossref_primary_10_1007_s13317_010_0011_7
crossref_primary_10_3389_fnut_2020_00006
crossref_primary_10_1002_jcla_23984
crossref_primary_10_1016_j_autrev_2018_03_009
crossref_primary_10_1097_MCO_0b013e3283566643
crossref_primary_10_1136_bcr_2013_201963
crossref_primary_10_1586_egh_13_5
crossref_primary_10_3109_08830185_2011_595854
crossref_primary_10_1186_s13075_014_0421_4
crossref_primary_10_1016_j_cppeds_2012_03_007
crossref_primary_10_1016_j_gastrohep_2015_09_018
crossref_primary_10_1155_2022_8502169
crossref_primary_10_5409_wjcp_v11_i3_296
crossref_primary_10_31146_1682_8658_ecg_188_4_84_95
crossref_primary_10_13070_rs_en_3_1487
crossref_primary_10_5409_wjcp_v11_i3_295
crossref_primary_10_1016_j_mser_2025_100943
crossref_primary_10_1016_j_gastrohep_2011_10_006
crossref_primary_10_3390_nu16111633
crossref_primary_10_1115_1_4025185
crossref_primary_10_1097_01_NPR_0000453647_38319_3c
crossref_primary_10_1249_JSR_0b013e31820f2eab
crossref_primary_10_3390_foods10081765
crossref_primary_10_1136_flgastro_2011_100089
crossref_primary_10_1089_act_2011_17205
crossref_primary_10_3390_nu15092051
crossref_primary_10_1097_MCG_0000000000000919
crossref_primary_10_3390_ijms242015482
crossref_primary_10_1016_j_crohns_2012_01_016
crossref_primary_10_1097_MD_0000000000001779
crossref_primary_10_1016_j_dld_2012_06_004
crossref_primary_10_26442_26586630_2023_3_202389
crossref_primary_10_1111_all_13354
crossref_primary_10_1136_amiajnl_2013_001924
crossref_primary_10_34172_mejdd_2023_356
crossref_primary_10_1016_j_gastre_2023_04_003
crossref_primary_10_1186_1741_7015_10_13
crossref_primary_10_1002_celc_201800743
crossref_primary_10_1586_17474124_2014_945915
crossref_primary_10_1109_TBME_2022_3157451
crossref_primary_10_3390_jcm8040540
crossref_primary_10_3390_nu11102345
crossref_primary_10_4103_jod_jod_170_24
crossref_primary_10_3390_nu16010083
crossref_primary_10_3109_00365521_2015_1017835
crossref_primary_10_1182_blood_2013_10_512624
crossref_primary_10_1097_PAS_0000000000001639
crossref_primary_10_3748_wjg_v28_i1_154
crossref_primary_10_1097_MPG_0b013e31823255c9
crossref_primary_10_17235_reed_2022_8962_2022
crossref_primary_10_5858_arpa_2016_0608_RA
crossref_primary_10_1016_j_jcs_2014_01_005
crossref_primary_10_1186_s13023_021_02050_6
crossref_primary_10_1016_j_cgh_2012_12_015
crossref_primary_10_1016_j_gastrohep_2023_04_003
crossref_primary_10_1590_S0103_84782013000500026
crossref_primary_10_1016_j_rbre_2014_10_003
crossref_primary_10_1177_20587384211008709
crossref_primary_10_1007_s13631_016_0134_6
crossref_primary_10_1136_bmjgast_2023_001252
crossref_primary_10_5858_arpa_2011_0572_RA
crossref_primary_10_34256_mdnt21311
crossref_primary_10_1016_j_lpmfor_2021_10_005
crossref_primary_10_1016_j_patol_2010_11_002
crossref_primary_10_1007_s10620_019_05528_3
crossref_primary_10_1097_MPG_0b013e31822a0128
crossref_primary_10_1371_journal_pone_0101249
crossref_primary_10_1542_peds_2015_3147
crossref_primary_10_1590_1806_9282_20221332
crossref_primary_10_1111_dom_12310
crossref_primary_10_1177_2050640616682181
crossref_primary_10_3390_mi15020287
crossref_primary_10_1016_j_giec_2012_07_004
crossref_primary_10_1016_j_rbr_2014_10_003
crossref_primary_10_1016_j_giec_2012_07_001
crossref_primary_10_1097_MPG_0b013e3182470249
crossref_primary_10_1016_j_dld_2010_12_003
crossref_primary_10_1186_s12916_019_1380_z
crossref_primary_10_1016_j_cca_2011_05_024
crossref_primary_10_17235_reed_2018_5941_2018
crossref_primary_10_3390_jcm12237386
crossref_primary_10_1007_s40744_018_0100_z
crossref_primary_10_1016_j_gastrohep_2022_03_011
crossref_primary_10_1038_ajg_2011_188
crossref_primary_10_1016_j_gastrohep_2014_01_005
crossref_primary_10_1186_1471_230X_13_19
crossref_primary_10_1016_j_jpeds_2012_05_008
crossref_primary_10_1186_s13256_017_1376_2
crossref_primary_10_1097_MCG_0b013e31827a6f83
crossref_primary_10_1016_j_med_2016_02_010
crossref_primary_10_31482_mmsl_2018_010
crossref_primary_10_1016_j_mechatronics_2016_05_001
crossref_primary_10_1016_j_fmc_2015_03_024
crossref_primary_10_1016_j_gastre_2016_07_008
crossref_primary_10_1016_j_gastre_2022_03_002
Cites_doi 10.1111/j.1365-2036.2006.02997.x
10.1016/j.dld.2009.04.004
10.1097/00005176-200501000-00001
10.1023/B:DDAS.0000026296.02308.00
10.1111/j.1572-0241.2007.01360.x
10.1016/S0198-8859(03)00027-2
10.1053/gast.2001.22123
10.1097/00042737-199910000-00019
10.1111/j.1365-2036.2008.03609.x
ContentType Journal Article
Copyright 2010 Elsevier Inc.
Elsevier Inc.
2015 INIST-CNRS
Copyright 2010 Elsevier Inc. All rights reserved.
Copyright Elsevier Sequoia S.A. Aug 2010
Copyright_xml – notice: 2010 Elsevier Inc.
– notice: Elsevier Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright 2010 Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Sequoia S.A. Aug 2010
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7TO
7TS
7U9
H94
K9.
7X8
DOI 10.1016/j.amjmed.2010.02.019
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Physical Education Index
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Neurosciences Abstracts
Physical Education Index
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
MEDLINE - Academic

AIDS and Cancer Research Abstracts

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1555-7162
EndPage 693
ExternalDocumentID 2117271641
20670718
23087559
10_1016_j_amjmed_2010_02_019
S0002934310003591
1_s2_0_S0002934310003591
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Center for Celiac Research, University of Maryland School of Medicine
GroupedDBID ---
--K
-~X
.-4
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1RT
1~5
23M
3O-
4.4
457
4CK
4G.
53G
5RE
5VS
6J9
7-5
AAEDT
AAEDW
AAFWJ
AALRI
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
AAYWO
ABLJU
ABMAC
ABOCM
ABPPZ
ABWVN
ACGFO
ACIUM
ACKOT
ACPRK
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
ADVLN
AENEX
AEUPX
AEVXI
AFFNX
AFHKK
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AGQPQ
AHHHB
AHMBA
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BELOY
BKOMP
C5W
CS3
EBS
EFJIC
EFKBS
EJD
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
J5H
K-O
KOM
L7B
LZ2
M29
M41
MO0
MVM
N4W
N9A
NQ-
O9-
OD.
OHT
OO~
P2P
PC.
PQQKQ
R2-
ROL
RPZ
SAE
SEL
SES
SSZ
TWZ
UBY
UHB
UHU
UNMZH
UV1
WH7
WOW
WUQ
X7M
XH2
XPP
YFH
YOC
YQJ
YYQ
Z5R
ZGI
ZUP
ZXP
AACTN
AAYOK
ADPAM
AFCTW
NCXOZ
PKN
RIG
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7TO
7TS
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c558t-b4531a1f21affb36f5811587dc38f0a2d9bbfdba659e30896c369357700bd34f3
ISSN 0002-9343
1555-7162
IngestDate Sun Aug 24 03:49:01 EDT 2025
Thu Jul 10 23:36:38 EDT 2025
Fri Jul 25 08:25:11 EDT 2025
Mon Jul 21 06:05:52 EDT 2025
Mon Jul 21 09:16:21 EDT 2025
Tue Jul 01 00:44:17 EDT 2025
Thu Apr 24 22:59:50 EDT 2025
Fri Feb 23 02:19:30 EST 2024
Sun Feb 23 10:18:48 EST 2025
Tue Aug 26 17:33:39 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Celiac disease
Diagnosis
Intestinal biopsy
Algorithm
Medicine
Immunopathology
Intestinal malabsorption
Digestive diseases
Intestinal disease
Complication
Coeliac disease
Decision tree
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright 2010 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c558t-b4531a1f21affb36f5811587dc38f0a2d9bbfdba659e30896c369357700bd34f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 20670718
PQID 746433086
PQPubID 950
PageCount 3
ParticipantIDs proquest_miscellaneous_754881176
proquest_miscellaneous_749011158
proquest_journals_746433086
pubmed_primary_20670718
pascalfrancis_primary_23087559
crossref_primary_10_1016_j_amjmed_2010_02_019
crossref_citationtrail_10_1016_j_amjmed_2010_02_019
elsevier_sciencedirect_doi_10_1016_j_amjmed_2010_02_019
elsevier_clinicalkeyesjournals_1_s2_0_S0002934310003591
elsevier_clinicalkey_doi_10_1016_j_amjmed_2010_02_019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-08-01
PublicationDateYYYYMMDD 2010-08-01
PublicationDate_xml – month: 08
  year: 2010
  text: 2010-08-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle The American journal of medicine
PublicationTitleAlternate Am J Med
PublicationYear 2010
Publisher Elsevier Inc
Elsevier
Elsevier Sequoia S.A
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Sequoia S.A
References Abrams, Diamond, Rotterdam (bib7) 2004; 49
Salmi, Collin, Järvinen (bib6) 2006; 24
Salmi, Collin, Reunala (bib4) 2010; 42
Hill, Holmes (bib5) 2008; 27
Karell, Louka, Moodie (bib9) 2003; 64
(bib3) 1990; 65
Fasano, Catassi (bib1) 2001; 120
Oberhuber, Granditsch, Vogelsang (bib8) 1999; 11
Hill, Dirks, Liptak (bib2) 2005; 40
Simell, Hoppu, Hekkala (bib10) 2007; 102
Hill (10.1016/j.amjmed.2010.02.019_bib2) 2005; 40
Simell (10.1016/j.amjmed.2010.02.019_bib10) 2007; 102
Abrams (10.1016/j.amjmed.2010.02.019_bib7) 2004; 49
(10.1016/j.amjmed.2010.02.019_bib3) 1990; 65
Salmi (10.1016/j.amjmed.2010.02.019_bib4) 2010; 42
Karell (10.1016/j.amjmed.2010.02.019_bib9) 2003; 64
Hill (10.1016/j.amjmed.2010.02.019_bib5) 2008; 27
Fasano (10.1016/j.amjmed.2010.02.019_bib1) 2001; 120
Oberhuber (10.1016/j.amjmed.2010.02.019_bib8) 1999; 11
Salmi (10.1016/j.amjmed.2010.02.019_bib6) 2006; 24
References_xml – volume: 27
  start-page: 572
  year: 2008
  end-page: 577
  ident: bib5
  article-title: Coeliac disease: a biopsy is not always necessary for diagnosis
  publication-title: Aliment Pharmacol Ther
– volume: 64
  start-page: 469
  year: 2003
  end-page: 477
  ident: bib9
  article-title: HLA type in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease
  publication-title: Hum Immunol
– volume: 49
  start-page: 546
  year: 2004
  end-page: 550
  ident: bib7
  article-title: Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy
  publication-title: Dig Dis Sci
– volume: 11
  start-page: 1185
  year: 1999
  end-page: 1194
  ident: bib8
  article-title: The histopathology of coeliac disease: time for a standardized report scheme for pathologists
  publication-title: Eur J Gastroenterol Hepatol
– volume: 102
  start-page: 2026
  year: 2007
  end-page: 2035
  ident: bib10
  article-title: Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study
  publication-title: Am J Gastroenterol
– volume: 65
  start-page: 909
  year: 1990
  end-page: 911
  ident: bib3
  article-title: Revised criteria for diagnosis of celiac disease
  publication-title: Arch Dis Child
– volume: 42
  start-page: 28
  year: 2010
  end-page: 32
  ident: bib4
  article-title: Diagnostic methods beyond conventional histology
  publication-title: Dig Liver Dis
– volume: 120
  start-page: 636
  year: 2001
  end-page: 651
  ident: bib1
  article-title: Current approaches to the diagnosis and treatment of celiac disease: an evolving spectrum
  publication-title: Gastroenterology
– volume: 40
  start-page: 1
  year: 2005
  end-page: 19
  ident: bib2
  article-title: Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 24
  start-page: 541
  year: 2006
  end-page: 552
  ident: bib6
  article-title: Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming celiac disease
  publication-title: Aliment Pharmacol Ther
– volume: 24
  start-page: 541
  year: 2006
  ident: 10.1016/j.amjmed.2010.02.019_bib6
  article-title: Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming celiac disease
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2006.02997.x
– volume: 42
  start-page: 28
  year: 2010
  ident: 10.1016/j.amjmed.2010.02.019_bib4
  article-title: Diagnostic methods beyond conventional histology
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2009.04.004
– volume: 40
  start-page: 1
  year: 2005
  ident: 10.1016/j.amjmed.2010.02.019_bib2
  article-title: Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/00005176-200501000-00001
– volume: 49
  start-page: 546
  year: 2004
  ident: 10.1016/j.amjmed.2010.02.019_bib7
  article-title: Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy
  publication-title: Dig Dis Sci
  doi: 10.1023/B:DDAS.0000026296.02308.00
– volume: 102
  start-page: 2026
  year: 2007
  ident: 10.1016/j.amjmed.2010.02.019_bib10
  article-title: Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2007.01360.x
– volume: 64
  start-page: 469
  year: 2003
  ident: 10.1016/j.amjmed.2010.02.019_bib9
  article-title: HLA type in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease
  publication-title: Hum Immunol
  doi: 10.1016/S0198-8859(03)00027-2
– volume: 120
  start-page: 636
  year: 2001
  ident: 10.1016/j.amjmed.2010.02.019_bib1
  article-title: Current approaches to the diagnosis and treatment of celiac disease: an evolving spectrum
  publication-title: Gastroenterology
  doi: 10.1053/gast.2001.22123
– volume: 65
  start-page: 909
  year: 1990
  ident: 10.1016/j.amjmed.2010.02.019_bib3
  article-title: Revised criteria for diagnosis of celiac disease
  publication-title: Arch Dis Child
– volume: 11
  start-page: 1185
  year: 1999
  ident: 10.1016/j.amjmed.2010.02.019_bib8
  article-title: The histopathology of coeliac disease: time for a standardized report scheme for pathologists
  publication-title: Eur J Gastroenterol Hepatol
  doi: 10.1097/00042737-199910000-00019
– volume: 27
  start-page: 572
  year: 2008
  ident: 10.1016/j.amjmed.2010.02.019_bib5
  article-title: Coeliac disease: a biopsy is not always necessary for diagnosis
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2008.03609.x
SSID ssj0000956
Score 2.3962662
Snippet Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is implemented....
Abstract Celiac disease is the only treatable autoimmune disease, provided that a correct diagnosis is achieved and a strict, lifelong gluten-free diet is...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 691
SubjectTerms Algorithm
Algorithms
Autoantibodies - analysis
Biological and medical sciences
Biopsy
Celiac disease
Celiac Disease - diagnosis
Celiac Disease - genetics
Celiac Disease - immunology
Celiac Disease - pathology
Diagnosis
Gastroenterology. Liver. Pancreas. Abdomen
General aspects
HLA Antigens - analysis
Humans
Internal Medicine
Intestinal biopsy
Intestinal Mucosa - pathology
Medical diagnosis
Medical sciences
Medical treatment
Other diseases. Semiology
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Title Celiac Disease Diagnosis: Simple Rules Are Better Than Complicated Algorithms
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0002934310003591
https://www.clinicalkey.es/playcontent/1-s2.0-S0002934310003591
https://dx.doi.org/10.1016/j.amjmed.2010.02.019
https://www.ncbi.nlm.nih.gov/pubmed/20670718
https://www.proquest.com/docview/746433086
https://www.proquest.com/docview/749011158
https://www.proquest.com/docview/754881176
Volume 123
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagkxASQtwpg8kPvFWpYjvOhbep2jSxCxK0om-WnSajVWmnJn3h13NO7FzGNjp4iarEt_p8Pj7HPhdCPiKhU8mMFyeGe4FhqWdgZ_L4LMlCHYeY9AqtLS7Ck0nweSqnbSq5yrukNMP0161-Jf9DVXgHdEUv2X-gbNMovIDfQF94AoXheS8aj7LlXKf1JQueo6LZ3LyycivmGPd3sNkus2KA5l2mctwZ4FF5a0gO4qZeXq438_KHC1u-aOHT3OZ0wkv8eRc_0iWI33NnO7JcN3jQhV7VLjRoads9XugYtzUcUUoPw0zZDeOWdzUbtX7DDi9xhymGNh_XDWZtzw0WQ_1zAYN3ZnZ86Dseei029sUXdTw5O1Pjo-n4IdnjoBTwHtk7PP36_bTdeZMqW28zvNpVsrLnu9nLXaLIkytdwALJbWaTu1WPSgQZPyNPne5ADy0QnpMH2eoFeXTuKPKSnFs8UIcH2uDhE7VooBUaKKCBWjRQRAPtoIG2aHhFJsdH49GJ59JleKmUcemZAPipZjlnOs-NCHMZg7gfR7NUxLmvYfUZk8-MDmWSCT9OwlSEiZBR5PtmJoJcvCa91XqVvSWUzYIUVGuWY2qrVHDDeW6kMIzr2BdZ3CeinjmVuljymNJkqWqjwYWy861wvpXPFcx3n3hNrSsbS2VHeVkTRdV-wrCzKcDPjnrRbfWywq2WQjFVQEn1DeWBRATVJZeQCevWdBKolSzv0efBNdQ0f5BjyE1Q2_tkv4aRasYRBaAQQIGwT2jzFfg7XtrpVbbeYhF0Dgc6_qWIhF2YsQhaeWPx2faObnggfr7b3f4-edyu__ekV2622QcQuEtz4NbZbz6w1fo
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Celiac+disease+diagnosis%3A+simple+rules+are+better+than+complicated+algorithms&rft.jtitle=The+American+journal+of+medicine&rft.au=Catassi%2C+Carlo&rft.au=Fasano%2C+Alessio&rft.date=2010-08-01&rft.issn=1555-7162&rft.eissn=1555-7162&rft.volume=123&rft.issue=8&rft.spage=691&rft_id=info:doi/10.1016%2Fj.amjmed.2010.02.019&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029343%2FS0002934310X00109%2Fcov150h.gif